TrialCell reports. Medicine2020

AKR-001, an Fc-FGF21 Analog, Showed Sustained Pharmacodynamic Effects on Insulin Sensitivity and Lipid Metabolism in Type 2 Diabetes Patients.

Allegra Kaufman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.